Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction.

Kaar, Stephen J; Nottage, Judith F; Angelescu, Ilinca; Marques, Tiago Reis; Howes, Oliver D

Kaar, Stephen J; Nottage, Judith F; Angelescu, Ilinca; Marques, Tiago Reis; Howes, Oliver D.

Afiliação

Kaar SJ; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Nottage JF; MRC London Institute of Medical Sciences, Hammersmith Hospital, London, UK.
Angelescu I; Division of Psychology and Mental Health, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK.
Marques TR; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Howes OD; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Clin EEG Neurosci ; 55(2): 203-213, 2024 Mar.

Article em En | MEDLINE | ID: mdl-36591873

Assuntos

Canais de Potássio; Esquizofrenia; Humanos; Canais de Potássio/farmacologia; Canais de Potássio/fisiologia; Eletroencefalografia; Interneurônios/fisiologia; Potássio/farmacologia

Palavras-chave

gamma oscillations; novel treatment; parvalbumin; potassium channels; psychosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Canais de Potássio Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google